---
title: "First-line therapies-of-renal-cell-carcinoma"
slug: "first-line-therapies-of-renal-cell-carcinoma"
date: "2024-01-03"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[Systemic therapy for metastatic clear cell RCC]]

# First-line therapies-of-renal-cell-carcinoma

## Favorable

- Cabozantinib+nivolumab
- Lenvatinib+pembrolizumab
- Axitinib+pembrolizumab

### Other

- Sunitinib
- Pazopanib
- Ipilimumab+nivolumab
- Axitinib+avelumab
- Cabozantinib
- High-dose IL-2a
- Axitiniba
- Surveillancea

---

## Intermediate/Poor

- Cabozantinib+nivolumab
- Lenvatinib+pembrolizumab
- Axitinib+pembrolizumab
- Ipilimumab+nivolumab
- Cabozantinib

### Other

- Axitinib+avelumab
- Sunitinib
- Pazopanib
- Axitiniba
- High-dose IL-2a
- Temsirolimusa
